Onconetix (ONCO) Net Cash Flow (2021 - 2026)

Onconetix (ONCO) has reported Net Cash Flow for 6 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Net Cash Flow rose 438.03% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $5.3 million, a 33322.21% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 225.69% from the prior year.
• Net Cash Flow was $2.3 million for Q2 2026 at Onconetix, up from -$1.5 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $16.7 million in Q1 2022 and troughed at -$12.0 million in Q2 2023.
• A 5-year average of $242295.3 and a median of -$300898.0 in 2024 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 6602.01% in 2022 and sank 431.22% in 2023, its largest moves.
• Over 5 years, Net Cash Flow stood at -$3.4 million in 2022, then climbed by 8.5% to -$3.1 million in 2023, then soared by 112.31% to $381279.0 in 2024, then jumped by 803.99% to $3.4 million in 2025, then tumbled by 34.71% to $2.3 million in 2026.
• The last three Net Cash Flow figures came in at $2.3 million (Q2 2026), -$1.5 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.